基于尿酸的比率用于预测中国IgA脏病患者的功能衰竭
Aiya Qin1, Dandan Yang1, Siqing Wang1
1Division of Nephrology, Department of Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
International journal of medical sciences
|October 20, 2023
概括
尿酸/白蛋白比 (UAR) 可以预测IgA脏病 (IgAN) 患者的病进展. 高的UAR表明患脏不良结果的风险更大,有助于有针对性的管理策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 生物标志物研究 生物标志物研究
- 临床医学 临床医学
背景情况:
- 尿酸/白蛋白比率 (UAR) 是一种新的生物标志物,具有疾病预测和预后的潜力.
- 在IgA脏病 (IgAN) 中UAR的预后价值仍然不清楚.
研究的目的:
- 调查尿酸/白蛋白比率 (UAR) 作为IgA脏病 (IgAN) 脏结果的预后指标.
主要方法:
- 对1143名经活检确认的Igan患者进行了回顾性队列研究 (2009-2017年).
- 通过ROC分析确定了脏结果的最佳UAR截止值.
- 将患者分为高和低UAR组.
- 分析了的终点,包括ESRD,eGFR下降和替代疗法启动.
- 使用了卡普兰-梅尔和考克斯回归分析.
主要成果:
- 9.94的UAR截止值被确定为预测性存活的最佳值 (AUC 0.750).
- 高UAR (≥9.94) 的患者表现出更严重的临床和病理特征.
- 在IgAN (HR=2.56,p=0.036) 中,高的UAR独立地与较高的不良结局风险相关.
结论:
- 尿酸/白蛋白比率 (UAR) 作为IgA脏病发作中脏进展的新和独立预测指标.
- UAR可能有助于识别高风险的患者,以有针对性的治疗和改善结果.
相关概念视频
Serum Studies: Renal Function Tests
9
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
9
Factors Affecting Renal Clearance: Renal Impairment
101
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
101
Acute Kidney Injury I: Introduction
14
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
14
Acute Kidney Injury IV: Diagnostic Studies and Prevention
19
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
19
Renal Failure: Dose Adjustments
97
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
97
Chronic Kidney Disease III: Interprofessional Care
21
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
21


